Back

GDF-15 is associated with worse ischemic and bleeding outcomes in the acute phase and during follow-up in patients with acute coronary syndrome: insights from the TRACER trial

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification in acute coronary syndromes (1) Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Charlotte Wassberg

Uppsala University, Uppsala (Sweden)

6 More presentations in this session

Presentation thumbnail
Checkpoint nano-degrader to transiently promote efferocytosis in acute myocardial infarction
Mr J. Gao (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
The specificity of cardiac troponin elevations for myocardial infarction declines with age
Doctor R. Hasselbalch (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Growth differentiation factor-15 is associated with myocardial infarction and death at 30 and 90 days in ED patients with suspected acute coronary syndrome
Doctor B. Allen (Gainesville, US)
Abstract Slides Video
Presentation thumbnail
Effect of symptoms recognition in patients with recurrent acute myocardial infarction: from KRAMI-RCC
Doctor K. Kim (Jinju, KR)
Abstract Slides Video
Presentation thumbnail
Effect of a restrictive vs. liberal blood transfusion strategy among patients with acute myocardial infarction and anemia according to heart failure. A subgroup analysis of the REALITY trial.
Professor G. Ducrocq (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in acute coronary syndromes (1)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Growth differentiation factor-15 and 5-years cardiovascular risk in chest pain patients presenting to the emergency department: a multicenter cohort study
thumbnail
Congress Presentation
Growth differentiation factor-15 is associated with myocardial infarction and death at 30 and 90 days in ED patients with suspected acute coronary syndrome
thumbnail
Congress Presentation
Plasma levels of human growth differentiation factor 15 (GDF-15) and their effect of alirocumab on major adverse cardiovascular events and all-cause death after acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources